September 28, 2022
TransCelerate CEO: Speeding drug development a ‘win-win’ for all concerned
Explore
News
September 26, 2022
Amgen VP Encouraged By Initial Clinical Trial Diversity Efforts
Explore
September 21, 2022
Apply Risk-Based Monitoring To Focus On The ‘Big 3’ – Timelines, Quality, And Budget
Explore
September 21, 2022
International Trial Organizations Address Reporting Of Unforeseen Disruptions
Explore
September 1, 2022
The Case For Implementing TransCelerate’s Modernization Of Statistical Analysis Framework
Explore
August 9, 2022
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforces
Explore
July 26, 2022
Q&A: CMO and development chief Dietmar Berger says Sanofi is ‘right there at the table’ on diversity efforts
Explore
July 11, 2022
The Case For Implementing TransCelerate’s Modernization Of Statistical Analysis Framework
Explore
June 24, 2022
Reducing Study Team Burden With Targeted Training
Explore
June 22, 2022
Why the pharma industry is developing a real-world data framework
Explore